Acute Myeloid Leukemia

Included Tests

Clinical Significance

This test is designed to aid in diagnosis and/or treatment strategy for patients with AML.

Specimen Requirements

5.0 mL Whole Blood in an Lavender Top Tube

Alternate Specimen

5.0 mL (2.0) Bone Marrow in an Lavender Top Tube - EDTA in a plastic vial
or
5.0 mL (2.0) Whole Blood in an Green Top Tube - Na Heparin in a plastic Vial
7 days Ambient, 7 days Refrigerated, Unacceptable Frozen
or
5.0 mL (2.0) Bone Marrow in an Green Top Tube - Na Heparin in a plastic Vial
7 days Ambient, 7 days Refrigerated, Unacceptable Frozen
or
20 uL of 10 ng/uL DNA, only accept extracted DNA when extraction or isolation is performed in an appropriately qualified laboratory such as a CLIA certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or CMS.

TransportAndStorage

14 days Ambient
14 days Refrigerated
Unacceptable Frozen

Collection Instructions

Requisition form and Pathology/Flow Cytometry Reports are required.

Minimum Volume

2.0 mL Whole Blood

Neonatal Volumne

Reference Range:

Please refer to Interpretive Report

Methodology:

• Long Range Polymerase Chain Reaction
• Next Generation Sequencing (NGS)

Clinical Significance

This test is designed to aid in diagnosis and/or treatment strategy for patients with AML.

CDM

00913333

CPT Coding

81450